Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016774 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-03 | APVO | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +9,582 | 40.1K | +31% | — |
| D | 2023-03-07 | 2023-03-03 | APVO | White Marvin L | Pres, CEO, Dir | M - OptEx | $0.00 | -9,582 | 19.2K | -33% | $0 |
| DM | 2023-03-07 | 2023-03-03 | APVO | White Marvin L | Pres, CEO, Dir | A - Grant | $0.00 | +77.5K | 38.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-03 | M | A | 9,582 | — | 40,137 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2023-03-03 | M | D | 9,582 | $0.00 | 19,168 | D | — · — to — | 9,582 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. |
| 3 | Derivative | Restricted Stock Unit | 2023-03-03 | A | A | 38,750 | $0.00 | 38,750 | D | — · — to — | 38,750 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) The RSUs vest in three approximately equal annual installments beginning on March 2, 2024. |
| 4 | Derivative | Stock Option (right to buy) | 2023-03-03 | A | A | 38,750 | $0.00 | 38,750 | D | $2.15 · — to 2033-03-02 | 38,750 Common Stock | (F4) The option vests in three approximately equal annual installments beginning on March 2, 2024. |